{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:24:10Z","timestamp":1770729850488,"version":"3.49.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharmthera.2026.108982","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:56:42Z","timestamp":1768237002000},"page":"108982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A dive into the untapped potential of marine compounds in counteracting neurodegeneration"],"prefix":"10.1016","volume":"279","author":[{"given":"In\u00eas","family":"Costa","sequence":"first","affiliation":[]},{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]},{"given":"Maria Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.108982_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117996","article-title":"Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions","volume":"256","author":"Abeysinghe","year":"2020","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer\u2019s disease - A randomized, double-blind, placebo-controlled, multi-Centre study (the Alphase study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Archives of Medical Science"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149949","article-title":"Galectin-3 in Alzheimer\u2019s disease: Pathological roles, biomarker potential, and therapeutic implications","volume":"1867","author":"Akash","year":"2025","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0020","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0025","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11011-015-9699-4","article-title":"The antioxidant effect of astaxanthin is higher in young mice than aged: A region specific study on brain","volume":"30","author":"Al-Amin","year":"2015","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2016.02.062","article-title":"Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice","volume":"777","author":"Al-Amin","year":"2016","journal-title":"European Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1517\/13543776.15.10.1377","article-title":"Marine compounds for the therapeutic treatment of neurological disorders","volume":"15","author":"Alonso","year":"2005","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0040","series-title":"Alzheimers dement","first-page":"1598","volume":"19(4)","author":"Alzheimer's disease facts and figures","year":"2023"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/md18060290","article-title":"Marine biocompounds for neuroprotection-A review","volume":"18","author":"B\u0103la\u0219a","year":"2020","journal-title":"Marine Drugs"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death & Differentiation"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0060","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.3390\/md12094934","article-title":"Bioactive compounds from macroalgae in the new millennium: Implications for neurodegenerative diseases","volume":"12","author":"Barbosa","year":"2014","journal-title":"Marine Drugs"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071456","article-title":"Fiscalin derivatives as potential neuroprotective agents","volume":"14","author":"Barreiro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson\u2019s brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Molecular Neurodegeneration"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/30.3.235","article-title":"Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients","volume":"30","author":"Bourdel-Marchasson","year":"2001","journal-title":"Age and Ageing"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/neu.2000.17.801","article-title":"Apoptosis: Overview and signal transduction pathways","volume":"17","author":"Bredesen","year":"2000","journal-title":"Journal of Neurotrauma"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF03654836","article-title":"The potential protective effect of tramiprosate (homotaurine) against Alzheimer\u2019s disease: A review","volume":"24","author":"Caltagirone","year":"2012","journal-title":"Aging Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0105","first-page":"60","article-title":"Metabolites from algae with economical impact","volume":"146","author":"Cardozo","year":"2007","journal-title":"Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/md16090340","article-title":"Bioactive compounds from Marine organisms: Potential for bone growth and healing","volume":"16","author":"Carson","year":"2018","journal-title":"Marine Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/md19010024","article-title":"Benefits under the sea: The role of Marine compounds in neurodegenerative disorders","volume":"19","author":"Catanesi","year":"2021","journal-title":"Marine Drugs"},{"issue":"111","key":"10.1016\/j.pharmthera.2026.108982_bb0120","doi-asserted-by":"crossref","first-page":"110040","DOI":"10.1039\/C6RA21697H","article-title":"Dieckol, an edible seaweed polyphenol, retards rotenone-induced neurotoxicity and \u03b1-synuclein aggregation in human dopaminergic neuronal cells","volume":"6","author":"Cha","year":"2016","journal-title":"RSC Advances"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0125","doi-asserted-by":"crossref","first-page":"H225","DOI":"10.1111\/j.1750-3841.2009.01274.x","article-title":"Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells","volume":"74","author":"Chan","year":"2009","journal-title":"Journal of Food Science"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.biopha.2018.12.151","article-title":"A review for the pharmacological effect of lycopene in central nervous system disorders","volume":"111","author":"Chen","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"47","key":"10.1016\/j.pharmthera.2026.108982_bb0135","doi-asserted-by":"crossref","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","article-title":"Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis","volume":"290","author":"Chen","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11684-011-0119-9","article-title":"The role of protein kinase C epsilon in neural signal transduction and neurogenic diseases","volume":"5","author":"Chen","year":"2011","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: The good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2004.08.017","article-title":"Aberrant \u03b4PKC activation in the spinal cord of wobbler mouse: A model of motor neuron disease","volume":"18","author":"Dave","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2014.00251","article-title":"Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients","volume":"5","author":"David","year":"2014","journal-title":"Frontiers in Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jnr.24249","article-title":"Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients","volume":"96","author":"Delic","year":"2018","journal-title":"Journal of Neuroscience Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.22051","article-title":"FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis","volume":"67","author":"Deng","year":"2010","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0175","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jsfa.2901","article-title":"Study on the effects of laminarin, a polysaccharide from seaweed, on gut characteristics","volume":"87","author":"Devill\u00e9","year":"2007","journal-title":"Journal of the Science of Food and Agriculture"},{"issue":"Supplement 1","key":"10.1016\/j.pharmthera.2026.108982_bb0180","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1182\/blood-2018-99-119758","article-title":"Pkc\u03b5 is a central regulator of mitochondrial function and metabolism in acute myeloid Leukemia","volume":"132","author":"Di Marcantonio","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1471-4159.2003.01563.x","article-title":"Protein kinase C-epsilon is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures","volume":"84","author":"Di-Capua","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom12050714","article-title":"Cerebral Iron deposition in neurodegeneration","volume":"12","author":"Dusek","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0195","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010002","article-title":"Anti-inflammatory effects of Marine bioactive compounds and their potential as functional food ingredients in the prevention and treatment of neuroinflammatory disorders","volume":"28","author":"Elbandy","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicologic Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ca.23792","article-title":"Apoptosis and its therapeutic implications in neurodegenerative diseases","volume":"35","author":"Erekat","year":"2022","journal-title":"Clinical Anatomy"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nature Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1134\/S1819712419040020","article-title":"Lipid peroxidation products in the blood plasma of patients with Parkinson\u2019s disease as possible biomarkers of different stages of the disease","volume":"13","author":"Fedorova","year":"2019","journal-title":"Neurochemical Journal"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0003-2670(02)01592-1","article-title":"Quantitation of \u03ba-, \u03b9- and \u03bb-carrageenans by mid-infrared spectroscopy and PLS regression","volume":"480","author":"Fern\u00e1ndez","year":"2003","journal-title":"Analytica Chimica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0230","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer\u2019s disease: An evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiological Reviews"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108982_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/md20110662","article-title":"Marine sources of DHA-rich phospholipids with anti-Alzheimer effect","volume":"20","author":"Ferreira","year":"2022","journal-title":"Marine Drugs"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1104393","article-title":"Serum inflammatory cytokines levels and the correlation analyses in Parkinson\u2019s disease","volume":"11","author":"Fu","year":"2023","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0245","article-title":"Carotenoids from Marine organisms: Biological functions and industrial applications","volume":"6","author":"Galasso","year":"2017","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0250","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death and Differentiation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0255","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.etap.2011.12.022","article-title":"Fucoidan, a sulfated polysaccharide from brown algae, improves cognitive impairment induced by infusion of a\u03b2 peptide in rats","volume":"33","author":"Gao","year":"2012","journal-title":"Environmental Toxicology and Pharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108982_bb0260","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.2174\/138920112803341761","article-title":"Brain drug delivery systems for neurodegenerative disorders","volume":"13","author":"Garbayo","year":"2012","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"Supplement","key":"10.1016\/j.pharmthera.2026.108982_bb0270","first-page":"126","article-title":"Extraction and measurement of homotaurine in algae","volume":"4","author":"Gheytasi","year":"2017","journal-title":"Research Journal of Pharmacognosy"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102941","article-title":"Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics","volume":"51","author":"Ghonimi","year":"2021","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.108982_bb0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0165-5728(02)00437-X","article-title":"Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis","volume":"135","author":"Gomes","year":"2003","journal-title":"Journal of Neuroimmunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12103560","article-title":"Mitochondrial aconitase enzymatic activity: A potential Long-term survival biomarker in the blood of ALS patients","volume":"12","author":"Gonz\u00e1lez-Mingot","year":"2023","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0290","doi-asserted-by":"crossref","DOI":"10.1590\/1519-6984.266795","article-title":"Potential of marine compounds in the treatment of neurodegenerative diseases: A review","volume":"83","author":"Guimar\u00e3es","year":"2023","journal-title":"Brazilian Journal of Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0295","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/1541-4337.12136","article-title":"Marine bioactive compounds and their health benefits: A review","volume":"14","author":"Hamed","year":"2015","journal-title":"Comprehensive Reviews in Food Science and Food Safety"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/md18070347","article-title":"Neuroprotective potentials of Marine algae and their bioactive metabolites: Pharmacological insights and therapeutic advances","volume":"18","author":"Hannan","year":"2020","journal-title":"Marine Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0305","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/md13031267","article-title":"Acetylated chitosan oligosaccharides act as antagonists against glutamate-induced PC12 cell death via Bcl-2\/Bax signal pathway","volume":"13","author":"Hao","year":"2015","journal-title":"Marine Drugs"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0310","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s42995-023-00172-3","article-title":"The neuroprotective effects of peracetylated chitosan oligosaccharides against \u03b2-amyloid-induced cognitive deficits in rats","volume":"5","author":"Hao","year":"2023","journal-title":"Mar Life Science and Technology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0315","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson\u2019s disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2018.02.024","article-title":"Carboxymethylated chitosan protects Schwann cells against hydrogen peroxide-induced apoptosis by inhibiting oxidative stress and mitochondria dependent pathway","volume":"825","author":"He","year":"2018","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0325","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species","volume":"44","author":"He","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0330","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40265-024-02067-8","article-title":"Effects of Oral ALZ-801\/Valiltramiprosate on plasma biomarkers, brain hippocampal volume, and cognition: Results of 2-year single-arm, open-label, phase 2 trial in APOE4 carriers with early Alzheimer\u2019s disease","volume":"84","author":"Hey","year":"2024","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0335","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-018-0554-0","article-title":"Discovery and identification of an endogenous metabolite of Tramiprosate and its prodrug ALZ-801 that inhibits Beta amyloid oligomer formation in the human brain","volume":"32","author":"Hey","year":"2018","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0340","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-024-02068-7","article-title":"Analysis of cerebrospinal fluid, plasma \u03b2-amyloid biomarkers, and cognition from a 2-year phase 2 trial evaluating Oral ALZ-801\/Valiltramiprosate in APOE4 carriers with early Alzheimer\u2019s disease using quantitative systems pharmacology model","volume":"84","author":"Hey","year":"2024","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","article-title":"Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of Tramiprosate in development for the treatment of Alzheimer\u2019s disease","volume":"57","author":"Hey","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082310","article-title":"Isolation of fucoxanthin from Sargassum oligocystum Montagne, 1845 seaweed in Vietnam and its neuroprotective activity","volume":"11","author":"Hong","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108982_bb0355","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","article-title":"Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression","volume":"45","author":"van Horssen","year":"2008","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0360","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.14604","article-title":"Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"148","author":"Hu","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0365","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1007\/s11033-019-04801-y","article-title":"Lycopene protects against t-BHP-induced neuronal oxidative damage and apoptosis via activation of the PI3K\/Akt pathway","volume":"46","author":"Huang","year":"2019","journal-title":"Molecular Biology Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0370","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","article-title":"Rotenone-induced model of Parkinson\u2019s disease: Beyond mitochondrial complex I inhibition","volume":"60","author":"Ibarra-Guti\u00e9rrez","year":"2023","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0375","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3233\/JAD-170969","article-title":"Effects of composite supplement containing astaxanthin and Sesamin on cognitive functions in people with mild cognitive impairment: A randomized, double-blind, Placebo-Controlled Trial","volume":"62","author":"Ito","year":"2018","journal-title":"Journal of Alzheimers Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0380","first-page":"249","article-title":"Current trends in etiology, prognosis and therapeutic aspects of Parkinson\u2019s disease: A review","volume":"88","author":"Jagadeesan","year":"2017","journal-title":"Acta Biomed"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0385","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: A critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb0390","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","article-title":"Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson\u2019s disease","volume":"36","author":"Kaur","year":"2011","journal-title":"Neurochemical Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030520","article-title":"Liposomal formulations enhance the anti-inflammatory effect of eicosapentaenoic acid in HL60 cells","volume":"14","author":"Kaur","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0400","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2017.00531","article-title":"Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients","volume":"8","author":"Khaibullin","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112179","article-title":"Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases","volume":"145","author":"Kohandel","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0410","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.1719902115","article-title":"Bryostatin-1 alleviates experimental multiple sclerosis","volume":"115","author":"Kornberg","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0415","first-page":"301","article-title":"Concepts and classification of neurodegenerative diseases","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handbook of Clinical Neurology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108982_bb0420","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular pathology of neurodegenerative diseases: Principles and practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"Journal of Clinical Pathology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0425","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11064-024-04103-1","article-title":"Pretreatment with liposome-encapsulated shrimp Shell extract attenuated neuronal damage and death in A\u03b21-42-induced memory deficits in rats","volume":"49","author":"Kuedo","year":"2024","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1193590","article-title":"Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders","volume":"16","author":"Kwon","year":"2023","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.108982_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612825","article-title":"The \u03b5-isozyme of protein kinase C (PKC\u03b5) is impaired in ALS motor cortex and its pulse activation by Bryostatin-1 produces Long term survival in degenerating SOD1-G93A motor neuron-like cells","volume":"24","author":"La Cognata","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0440","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1471-4159.1995.65020927.x","article-title":"A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis","volume":"65","author":"Lanius","year":"1995","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0445","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.fct.2010.10.029","article-title":"Astaxanthin protects against MPTP\/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro","volume":"49","author":"Lee","year":"2011","journal-title":"Food and Chemical Toxicology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0450","article-title":"The role of fucoxanthin as a potent Nrf2 activator via Akt\/GSK-3\u03b2\/Fyn Axis against amyloid-\u03b2 peptide-induced oxidative damage","volume":"12","author":"Lee","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"Leray","year":"2016","journal-title":"Revue Neurologique (Paris)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0460","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/brb3.75","article-title":"Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"2","author":"Lerman","year":"2012","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/md15020049","article-title":"Extraction and identification of Phlorotannins from the Brown alga, Sargassum fusiforme (Harvey) Setchell","volume":"15","author":"Li","year":"2017","journal-title":"Marine Drugs"},{"issue":"7113","key":"10.1016\/j.pharmthera.2026.108982_bb0470","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0475","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4062\/biomolther.2016.181","article-title":"Marine-derived pharmaceuticals - Challenges and opportunities","volume":"24","author":"Lindequist","year":"2016","journal-title":"Biomolecules and Therapeutics (Seoul)"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0480","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijbiomac.2018.02.109","article-title":"The effect of different substitute groups and molecular weights of fucoidan on neuroprotective and anticomplement activity","volume":"113","author":"Liu","year":"2018","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0485","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3164\/jcbn.2008040","article-title":"DHA hydroperoxides as a potential inducer of neuronal cell death: A mitochondrial dysfunction-mediated pathway","volume":"43","author":"Liu","year":"2008","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0490","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2008.11.076","article-title":"Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism","volume":"1254","author":"Liu","year":"2009","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0495","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/molecules24030534","article-title":"Synthesis of new proteomimetic quinazolinone alkaloids and evaluation of their neuroprotective and antitumor effects","volume":"24","author":"Long","year":"2019","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0500","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/md9061056","article-title":"Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases","volume":"9","author":"Lordan","year":"2011","journal-title":"Marine Drugs"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0505","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","article-title":"Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer\u2019s disease","volume":"173","author":"Louneva","year":"2008","journal-title":"The American Journal of Pathology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0510","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2026.108982_bb0515","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2009.06.015","article-title":"Fucoidan protects against dopaminergic neuron death in vivo and in vitro","volume":"617","author":"Luo","year":"2009","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0520","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0975-7406.171700","article-title":"Exploring the ocean for new drug developments: Marine pharmacology","volume":"8","author":"Malve","year":"2016","journal-title":"Journal of Pharmacy & Bioallied Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0525","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12640-018-9978-z","article-title":"Low molecular weight Sulfated chitosan: Neuroprotective effect on rotenone-induced in vitro Parkinson\u2019s disease","volume":"35","author":"Manigandan","year":"2019","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00614","article-title":"A review on Tramiprosate (homotaurine) in Alzheimer\u2019s disease and other neurocognitive disorders [review]","volume":"11","author":"Manzano","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0535","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","article-title":"Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer\u2019s disease","volume":"150","author":"Marcus","year":"1998","journal-title":"Experimental Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090242","article-title":"Marine natural products, multitarget therapy and repurposed agents in Alzheimer\u2019s disease","volume":"13","author":"Martins","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0545","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0550","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s13738-017-1150-9","article-title":"Simultaneous screening of homotaurine and taurine in marine macro-algae using liquid chromatography\u2013fluorescence detection","volume":"14","author":"Mehdinia","year":"2017","journal-title":"Journal of the Iranian Chemical Society"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochemical Pharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2026.108982_bb0560","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.3233\/JAD-2010-100345","article-title":"Mitochondria dysfunction and neurodegenerative disorders: Cause or consequence","volume":"20","author":"Morais","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0570","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death and Differentiation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0575","first-page":"104","article-title":"Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration","volume":"21","author":"Nagase","year":"2016","journal-title":"Redox Report"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0580","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-170161","article-title":"Bryostatin effects on cognitive function and PKC\u025b in Alzheimer\u2019s disease phase IIa and expanded access trials","volume":"58","author":"Nelson","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/BJ20091302","article-title":"The substrates and binding partners of protein kinase Cepsilon","volume":"427","author":"Newton","year":"2010","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0590","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.carbpol.2015.08.055","article-title":"Antioxidant and neuroprotective potential of chitooligomers in Caenorhabditis elegans exposed to Monocrotophos","volume":"135","author":"Nidheesh","year":"2016","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0595","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuroscience.2018.01.005","article-title":"Profiles of \u03b2-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE \u03b54 status: Impact for risk and progression of Alzheimer disease","volume":"373","author":"Nyarko","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.carres.2017.01.007","article-title":"4-hydroxybenzaldehyde-chitooligomers suppresses H(2)O(2)-induced oxidative damage in microglia BV-2 cells","volume":"440-441","author":"Oh","year":"2017","journal-title":"Carbohydrate Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0605","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","article-title":"Alzheimer\u2019s disease: Natural products as inhibitors of neuroinflammation","volume":"28","author":"Olajide","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainresbull.2022.11.018","article-title":"Multiple roles of fucoxanthin and astaxanthin against Alzheimer\u2019s disease: Their pharmacological potential and therapeutic insights","volume":"193","author":"Oliyaei","year":"2023","journal-title":"Brain Research Bulletin"},{"issue":"Pt B","key":"10.1016\/j.pharmthera.2026.108982_bb0615","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.brainres.2016.04.010","article-title":"Protein folding alterations in amyotrophic lateral sclerosis","volume":"1648","author":"Parakh","year":"2016","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0620","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4014\/jmb.1710.10043","article-title":"Protective effect of fucoidan extract from Ecklonia cava on hydrogen peroxide-induced neurotoxicity","volume":"28","author":"Park","year":"2018","journal-title":"Journal of Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104823","article-title":"Lycopene - A pleiotropic neuroprotective nutraceutical: Deciphering its therapeutic potentials in broad spectrum neurological disorders","volume":"140","author":"Paul","year":"2020","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1110520","article-title":"Retinal fingerprints of ALS in patients: Ganglion cell apoptosis and TDP-43\/p62 misplacement","volume":"15","author":"Pediconi","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0635","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3390\/md9101806","article-title":"Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health","volume":"9","author":"Peng","year":"2011","journal-title":"Marine Drugs"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0640","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.foodhyd.2008.11.014","article-title":"Identification of selected seaweed polysaccharides (phycocolloids) by vibrational spectroscopy (FTIR-ATR and FT-Raman)","volume":"23","author":"Pereira","year":"2009","journal-title":"Food Hydrocolloids"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0650","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1007\/s11033-022-07369-2","article-title":"Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway","volume":"49","author":"Preethi","year":"2022","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0655","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2015.05.024","article-title":"Neuroprotective effect of lycopene against MPTP induced experimental Parkinson\u2019s disease in mice","volume":"599","author":"Prema","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0660","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1007\/s12035-019-1527-0","article-title":"Delayed Galectin-3-mediated reprogramming of microglia after stroke is protective","volume":"56","author":"Rahimian","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"42","key":"10.1016\/j.pharmthera.2026.108982_bb0665","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1523\/JNEUROSCI.1157-19.2019","article-title":"Pleiotropic mitochondria: The influence of mitochondria on neuronal development and disease","volume":"39","author":"Rangaraju","year":"2019","journal-title":"The Journal of Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.108982_bb0670","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/1028415021000033767","article-title":"Role of oxidative stress and antioxidants in neurodegenerative diseases","volume":"5","author":"Rao","year":"2002","journal-title":"Nutritional Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0675","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/14737159.2015.1002469","article-title":"Genetic diagnosis and prognosis of Alzheimer\u2019s disease: Challenges and opportunities","volume":"15","author":"Reitz","year":"2015","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0680","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/1523-1747.ep12394957","article-title":"Translocation and downregulation of protein kinase C isoenzymes-alpha and -epsilon by phorbol ester and bryostatin-1 in human keratinocytes and fibroblasts","volume":"103","author":"Reynolds","year":"1994","journal-title":"The Journal of Investigative Dermatology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0685","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10072-015-2201-6","article-title":"Homotaurine in Parkinson\u2019s disease","volume":"36","author":"Ricciardi","year":"2015","journal-title":"Neurological Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0690","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer\u2019s disease","volume":"57","author":"Richard","year":"2019","journal-title":"Folia Neuropathologica"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0695","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.fbp.2024.02.007","article-title":"Omega-3 fatty acids from fish by-products: Innovative extraction and application in food and feed","volume":"145","author":"Rodrigues","year":"2024","journal-title":"Food and Bioproducts Processing"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.108982_bb0700","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/antiox12112014","article-title":"Antioxidants of non-enzymatic nature: Their function in higher plant cells and the ways of boosting their biosynthesis","volume":"12","author":"Rudenko","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0705","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/md14010005","article-title":"New drugs from Marine organisms in Alzheimer\u2019s disease","volume":"14","author":"Russo","year":"2015","journal-title":"Marine Drugs"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0710","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","article-title":"Neuropathology of amyotrophic lateral sclerosis and its variants","volume":"33","author":"Saberi","year":"2015","journal-title":"Neurologic Clinics"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0715","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jnutbio.2015.01.012","article-title":"Lycopene abrogates a\u03b2(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer\u2019s disease","volume":"26","author":"Sachdeva","year":"2015","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.108982_bb0720","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/ja00280a055","article-title":"Manzamine A, a novel antitumor alkaloid from a sponge","volume":"108","author":"Sakai","year":"1986","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0725","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10242422.2017.1295231","article-title":"Enzymatic production of fully deacetylated chitooligosaccharides and their neuroprotective and anti-inflammatory properties","volume":"36","author":"Santos-Moriano","year":"2018","journal-title":"Biocatalysis and Biotransformation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0730","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Current Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0735","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0891-5849(98)00021-5","article-title":"(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Selley","year":"1998","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0740","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative stress: A concept in redox biology and medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/md19070373","article-title":"Exploitation of Marine molecules to manage Alzheimer\u2019s disease","volume":"19","author":"Silva","year":"2021","journal-title":"Marine Drugs"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2026.108982_bb0750","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotoxicity Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clinics in Geriatric Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0760","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106737","article-title":"Lipid mediated brain disorders: A perspective","volume":"167","author":"Singh","year":"2023","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0770","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molmed.2008.12.004","article-title":"Heme oxygenase-1: From biology to therapeutic potential","volume":"15","author":"Soares","year":"2009","journal-title":"Trends in Molecular Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.108982_bb0775","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-150484","article-title":"Homotaurine effects on hippocampal volume loss and episodic memory in amnestic mild cognitive impairment","volume":"50","author":"Spalletta","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0780","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005072-199701000-00009","article-title":"Bax protein expression is increased in Alzheimer\u2019s brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology","volume":"56","author":"Su","year":"1997","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0785","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tifs.2016.01.019","article-title":"Marine bioactive compounds and health promoting perspectives; innovation pathways for drug discovery","volume":"50","author":"Suleria","year":"2016","journal-title":"Trends in Food Science & Technology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/md17020121","article-title":"9-Methylfascaplysin is a more potent a\u03b2 aggregation inhibitor than the Marine-derived alkaloid, Fascaplysin, and produces nanomolar neuroprotective effects in SH-SY5Y cells","volume":"17","author":"Sun","year":"2019","journal-title":"Marine Drugs"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0795","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A Meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0800","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: Implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0805","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40265-020-01268-1","article-title":"Sodium Oligomannate: First approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0810","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.carbpol.2010.01.052","article-title":"Structure and antitumour activity of fucoidan isolated from sporophyll of Korean brown seaweed Undaria pinnatifida","volume":"81","author":"Synytsya","year":"2010","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0815","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1570159X14666151208112754","article-title":"Current treatment options for Alzheimer\u2019s disease and Parkinson\u2019s disease dementia","volume":"14","author":"Szeto","year":"2016","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0820","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/B978-0-12-802973-2.00013-6","article-title":"The epidemiology of amyotrophic lateral sclerosis","volume":"138","author":"Talbott","year":"2016","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0825","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1039\/b307243f","article-title":"The cerebrosides","volume":"20","author":"Tan","year":"2003","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0830","series-title":"Progress in molecular biology and translational science","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/bs.pmbts.2019.02.012","article-title":"Chapter eighteen - biological mechanisms of glycan- and glycosaminoglycan-based nutraceuticals","volume":"163","author":"Tang","year":"2019"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0835","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson\u2019s disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.813951","article-title":"IL-33 and IL-10 serum levels increase in MCI patients following homotaurine treatment","volume":"13","author":"Toppi","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041035","article-title":"An in vitro evaluation of the potential neuroprotective effects of intranasal lipid nanoparticles containing astaxanthin obtained from different sources: Comparative studies","volume":"15","author":"Torres","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb0850","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/dneu.22137","article-title":"Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis","volume":"74","author":"Tury","year":"2014","journal-title":"Developmental Neurobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0855","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70133","article-title":"Oxidative\/nitrosative stress, apoptosis, and redox Signaling: Key players in neurodegenerative diseases","volume":"39","author":"\u00dcremi\u015f","year":"2025","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0860","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.108982_bb0865","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.molmed.2019.04.010","article-title":"Astrocytes: Emerging therapeutic targets in neurological disorders","volume":"25","author":"Valori","year":"2019","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0870","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine","volume":"39","author":"Wallace","year":"2005","journal-title":"Annual Review of Genetics"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.108982_bb0875","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0880","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jff.2018.09.027","article-title":"A comparative study about EPA-PL and EPA-EE on ameliorating behavioral deficits in MPTP-induced mice with Parkinson\u2019s disease by suppressing oxidative stress and apoptosis","volume":"50","author":"Wang","year":"2018","journal-title":"Journal of Functional Foods"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0885","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijbiomac.2009.10.015","article-title":"Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica","volume":"46","author":"Wang","year":"2010","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0890","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2020.107798","article-title":"Isolation and purification of brown algae fucoidan from Sargassum siliquosum and the analysis of anti-lipogenesis activity","volume":"165","author":"Wang","year":"2021","journal-title":"Biochemical Engineering Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0900","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","article-title":"A phase II randomized trial of sodium oligomannate in Alzheimer\u2019s dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0905","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death and Differentiation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0910","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","article-title":"Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer\u2019s disease patients","volume":"173","author":"Wang","year":"2008","journal-title":"The American Journal of Pathology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0915","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.108982_bb0920","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.108982_bb0925","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuropharm.2011.09.016","article-title":"\u0391-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates \u03b2-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation","volume":"62","author":"Wang","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/md21070410","article-title":"A comparative study about the neuroprotective effects of DHA-enriched phosphatidylserine and EPA-enriched phosphatidylserine against oxidative damage in primary hippocampal neurons","volume":"21","author":"Wang","year":"2023","journal-title":"Marine Drugs"},{"issue":"4\u20136","key":"10.1016\/j.pharmthera.2026.108982_bb0935","first-page":"659","article-title":"Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression","volume":"26","author":"Weihe","year":"2006","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb0940","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.108982_bb0945","article-title":"N-3 PUFA-deficiency in early life exhibits aggravated MPTP-induced neurotoxicity in old age while supplementation with DHA\/EPA-enriched phospholipids exerts a neuroprotective effect","volume":"65","author":"Wu","year":"2021","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0950","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuint.2013.10.015","article-title":"The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 mice","volume":"64","author":"Wu","year":"2014","journal-title":"Neurochemistry International"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0955","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/chem.201903128","article-title":"Unlocking the drug potential of the Bryostatin family: Recent advances in product synthesis and biomedical applications","volume":"26","author":"Wu","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.pharmthera.2026.108982_bb0960","article-title":"Fucoxanthin prevents 6-OHDA-induced neurotoxicity by targeting Keap1","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.108982_bb0965","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248714","article-title":"A review: Meridianins and Meridianins derivatives","volume":"27","author":"Xiao","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb0970","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","article-title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.108982_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28553","article-title":"Serum cytokines profile changes in amyotrophic lateral sclerosis","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"issue":"34","key":"10.1016\/j.pharmthera.2026.108982_bb0980","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1021\/acs.jafc.1c00569","article-title":"PLGA-PEG nanoparticles facilitate in vivo anti-Alzheimer\u2019s effects of fucoxanthin, a Marine carotenoid derived from edible Brown algae","volume":"69","author":"Yang","year":"2021","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0985","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: Symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.108982_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/md15060183","article-title":"Compositional characteristics and in vitro evaluations of antioxidant and neuroprotective properties of crude extracts of fucoidan prepared from compressional puffing-pretreated Sargassum crassifolium","volume":"15","author":"Yang","year":"2017","journal-title":"Marine Drugs"},{"issue":"7745","key":"10.1016\/j.pharmthera.2026.108982_bb0995","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb1000","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11064-013-1079-z","article-title":"Lycopene protects against MPP(+)-induced cytotoxicity by maintaining mitochondrial function in SH-SY5Y cells","volume":"38","author":"Yi","year":"2013","journal-title":"Neurochemical Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.108982_bb1005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/cells14080571","article-title":"Natural products in the treatment of neuroinflammation at microglia: Recent trend and features","volume":"14","author":"Yoon","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2026.108982_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115774","article-title":"Biomedical applications of laminarin","volume":"232","author":"Zargarzadeh","year":"2020","journal-title":"Carbohydrate Polymer"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.108982_bb1015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.14336\/AD.2017.0831","article-title":"Fucoidan protects dopaminergic neurons by enhancing the mitochondrial function in a rotenone-induced rat model of Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Aging and Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.108982_bb1020","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/s41598-017-02825-7","article-title":"Release of cytochrome C from Bax pores at the mitochondrial membrane","volume":"7","author":"Zhang","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.108982_bb1025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.plefa.2017.07.003","article-title":"DHA, EPA and their combination at various ratios differently modulated a\u03b2(25-35)-induced neurotoxicity in SH-SY5Y cells","volume":"136","author":"Zhang","year":"2018","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2026.108982_bb1030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Molecules Brain"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.108982_bb1035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12325-009-0082-x","article-title":"Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis","volume":"26","author":"Zwibel","year":"2009","journal-title":"Advances in Therapy"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:44:49Z","timestamp":1770655489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":206,"alternative-id":["S0163725826000094"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108982","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dive into the untapped potential of marine compounds in counteracting neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108982"}}